Position in VRTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$672,572
+$44,291 QoQ
Shares Held
1,354
-3.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#974
of 1,735 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PDS Planning, Inc holds $2,326,019 across 8 Biotechnology names. VRTX ranks #1 (28.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,354 | $672,572 | |
| 2 | ARGX |
Argenx SE
|
394 | $365,541 | |
| 3 | RPRX |
Royalty Pharma plc
|
5,059 | $283,658 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
416 | $259,392 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,128 | $254,963 | |
| 6 | HELP |
Cybin Inc.
|
30,344 | $200,573 | |
| 7 | GMAB |
Genmab A/S
|
7,293 | $200,338 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
|
24,246 | $88,982 |
All Filings in VRTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $672,572 | 1,354 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $628,281 | 1,407 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $597,075 | 1,317 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $447,644 | 1,143 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $553,383 | 1,243 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $561,421 | 1,158 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $331,824 | 824 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $391,597 | 842 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $382,006 | 815 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $344,022 | 823 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $316,153 | 777 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $266,368 | 766 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $265,692 | 755 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $293,015 | 930 | Shares | Sole | 2023-05-02 | |
| No filing history on record for this holder in this stock. | ||||||